Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jul 19, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN | PENUMBRA INC | NYSE | Medical Devices | A | $8.91B | $230.10 | -1.84% | $71.30M | 209.18x | 0.31 | United States | 51 |
| BGC | BGC GROUP INC | NASDAQ | Capital Markets | A | $5.03B | $10.31 | 1.58% | $365.61M | 36.82x | 3.88 | United States | 41 |
| ACIW | ACI WORLDWIDE INC | NASDAQ | Software - Infrastructure | A | $4.79B | $45.70 | 3.25% | $514.57M | 17.78x | 1.16 | United States | 47 |
| KMPR | KEMPER CORP | NYSE | Insurance - Property & Casualty | A | $3.97B | $62.02 | 1.84% | $486.60M | 11.49x | 3.28 | United States | 26 |
| GRND | GRINDR INC | NYSE | Software - Application | A | $3.91B | $19.94 | -5.90% | -$39.32M | -36.25x | 1.12 | United States | 24 |
| ENS | ENERSYS | NYSE | Electrical Equipment & Parts | A | $3.51B | $89.52 | 3.25% | $558.57M | 9.78x | 1.07 | United States | 50 |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | NASDAQ | Health Information Services | A | $3.50B | $20.10 | 0.20% | $468.92M | 67.00x | 2.46 | United States | 29 |
| AMRX | AMNEAL PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.58B | $8.24 | -0.24% | $503.18M | -206.00x | -26.56 | 25 | |
| DCO | DUCOMMUN INC | NYSE | Aerospace & Defense | A | $1.29B | $86.81 | 0.36% | $98.47M | 36.63x | 0.63 | United States | 46 |
| ATRO | ASTRONICS CORP | NASDAQ | Aerospace & Defense | A | $1.24B | $34.95 | 1.69% | $55.40M | -317.73x | 1.48 | United States | 26 |
| EVER | EVERQUOTE INC | NASDAQ | Internet Content & Information | A | $892.71M | $24.69 | 0.73% | $46.12M | 22.86x | 0.55 | United States | 56 |
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | A | $815.66M | $10.36 | -9.96% | $16.04M | 57.53x | 0.47 | United States | 49 |
| DLX | DELUXE CORP | NYSE | Advertising Agencies | A | $726.13M | $16.23 | 1.06% | $378.67M | 12.88x | 3.14 | United States | 51 |
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | A | $692.24M | $12.66 | 2.76% | -$60.30M | -6.59x | 3.21 | United States | 33 |
| HRTG | HERITAGE INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $667.60M | $21.54 | -0.46% | $123.55M | 8.48x | 5.73 | United States | 38 |
| LYTS | LSI INDUSTRIES INC | NASDAQ | Electronic Components | A | $525.98M | $17.53 | 0.11% | $44.29M | 23.69x | 0.74 | United States | 56 |
| KMDA | KAMADA LTD | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $427.26M | $7.43 | -1.72% | $32.38M | 26.54x | 0.49 | Israel | 51 |
| NEXN | NEXXEN INTERNATIONAL LTD | NASDAQ | Advertising Agencies | A | $328.80M | $10.03 | 1.31% | $114.98M | 8.50x | 0.50 | Israel | 41 |
| QUAD | QUAD/GRAPHICS INC | NYSE | Specialty Business Services | A | $277.36M | $5.48 | 1.86% | $143.30M | -15.22x | 13.26 | United States | 16 |
| BKTI | BK TECHNOLOGIES CORP | NYSEMKT | Communication Equipment | A | $152.09M | $41.40 | 1.97% | $11.28M | 15.00x | 0.73 | United States | 40 |
| MAPS | WM TECHNOLOGY INC | NASDAQ | Software - Application | A | $149.90M | $0.97 | 2.64% | $24.98M | 12.14x | 1.24 | United States | 40 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.